← Evidence map

ReviewDrug design, development and therapy2017

Profile of mirabegron in the treatment of overactive bladder: place in therapy.

Ala'a Sharaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28255232